We are live on
!
Find out more
DAM
DLD Asset Management Portfolio holdings
AUM
$1.51B
Turnover
51.11%
1-Year Est. Return
5.32%
This Fund
S&P 500
This Quarter
Est. Return
+7.16%
1 Year Est. Return
+5.32%
3 Year Est. Return
+10.27%
5 Year Est. Return
+32.59%
10 Year Est. Return
–
AUM
$2.72B
AUM Growth
+$1.26B
(+86%)
Cap. Flow
-$390M
Cap. Flow
% of AUM
-14.37%
Top 10 Holdings %
Top 10 Hldgs %
63.11%
Holding
138
New
54
Increased
15
Reduced
11
Closed
39
Avg Time Held Equity + Options
0.2
years
Top 10 Avg Time Held Equity + Options
0.2
years
Top 20 Avg Time Held Equity + Options
0.2
years
Avg Time Held Equity only
0.2
years
Top 10 Avg Time Held Equity only
0.3
years
Top 20 Avg Time Held Equity only
0.2
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$109M |
| 2 |
Amgen
AMGN
|
+$53.5M |
| 3 |
CELG
Celgene Corp
CELG
|
+$30.6M |
| 4 |
FDC
First Data Corporation
FDC
|
+$27.3M |
| 5 |
Truist Financial
TFC
|
+$23.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Qualcomm
QCOM
|
+$62.5M |
| 2 |
SHPG
Shire pic
SHPG
|
+$38M |
| 3 |
DISCK
Discovery, Inc. Series C Common Stock
DISCK
|
+$36.9M |
| 4 |
TFCFA
Twenty-First Century Fox, Inc. Class A
TFCFA
|
+$33.7M |
| 5 |
SEND
SendGrid, Inc.
SEND
|
+$28.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 78.7% |
| 2 | Healthcare | 7.97% |
| 3 | Technology | 6.1% |
| 4 | Communication Services | 2.23% |
| 5 | Financials | 1.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
ATTU
26
DELISTED
Attunity Ltd
ATTU
| $10.6M | 0.39% |
+450,000
| New | +$10M |
2019 Q1
0 quarters
|
|
|
TRCO
27
DELISTED
TRIBUNE MEDIA COMPANY CLASS A
TRCO
| $10.4M | 0.38% |
225,000
-22,129
| -9% | -$1.02M |
2017 Q2
7 quarters
|
|
|
OAK
28
DELISTED
OAKTREE CAPITAL GROUP, LLC
OAK
| $10.1M | 0.37% |
+204,000
| New | +$8.86M |
2019 Q1
0 quarters
|
|
|
LEXEA
29
DELISTED
Liberty Expedia Holdings, Inc. Class A Common Stock
LEXEA
| $10.1M | 0.37% |
+235,000
| New | +$10.1M |
2019 Q1
0 quarters
|
|
30
Pacific Biosciences
PACB
$609M
| $10.1M | 0.37% |
1,390,000
-343,340
| -20% | -$2.48M |
2018 Q4
1 quarter
|
|
|
ARRS
31
DELISTED
ARRIS International plc Ordinary Shares
ARRS
| $8.56M | 0.32% |
270,900
| – | – |
2018 Q4
1 quarter
|
|
|
MLNX
32
DELISTED
Mellanox Technologies, Ltd.
MLNX
| $8.29M | 0.31% |
+70,000
| New | +$7.04M |
2019 Q1
0 quarters
|
|
33
Liberty Global Class A
LBTYA
$2.74B
| $7.48M | 0.28% |
300,000
+30,217
| +11% | +$739K |
2018 Q1
4 quarters
|
|
|
NAVG
34
DELISTED
Navigators Group Inc
NAVG
| $7.44M | 0.27% |
106,478
-8,467
| -7% | -$591K |
2018 Q3
2 quarters
|
|
35
CALL
Tvardi Therapeutics
TVRD
$14.3M
| $6.93M | 0.26% |
+9,797
| New | +$5.86M |
2019 Q1
0 quarters
|
|
36
PUT
Travere Therapeutics
TVTX
$4.98B
| $6.01M | 0.22% |
+265,600
| New | +$5.87M |
2019 Q1
0 quarters
|
|
37
PUT
Elevance Health
ELV
$92.9B
| $5.74M | 0.21% |
+20,000
| New | +$5.78M |
2019 Q1
0 quarters
|
|
38
DELISTED
Nightstar Therapeutics plc American Depositary Shares
NITE
| $4.59M | 0.17% |
+181,075
| New | +$3.2M |
2019 Q1
0 quarters
|
|
39
Stewart Information Services
STC
$1.59B
| $4.42M | 0.16% |
103,638
| – | – |
2018 Q2
3 quarters
|
|
|
ELLI
40
DELISTED
Ellie Mae Inc
ELLI
| $4.24M | 0.16% |
+42,935
| New | +$3.73M |
2019 Q1
0 quarters
|
|
41
DELISTED
SI Financial Group, Inc. NEW MD
SIFI
| $4.18M | 0.15% |
323,436
+37,236
| +13% | +$509K |
2018 Q4
1 quarter
|
|
|
IMDZ
42
DELISTED
Immune Design Corp.
IMDZ
| $3.51M | 0.13% |
+600,030
| New | +$2.04M |
2019 Q1
0 quarters
|
|
|
WBC
43
DELISTED
WABCO HOLDINGS INC.
WBC
| $3.44M | 0.13% |
+26,112
| New | +$3.22M |
2019 Q1
0 quarters
|
|
44
PUT
DELISTED
Immunogen Inc
IMGN
| $3.35M | 0.12% |
+1,239,500
| New | +$5.37M |
2019 Q1
0 quarters
|
|
|
45
DELISTED
Immunogen Inc
IMGN
| $3.21M | 0.12% |
+1,186,300
| New | +$5.14M |
2019 Q1
0 quarters
|
|
46
Fox Class A
FOXA
$27B
| $3.02M | 0.11% |
+82,349
| New | +$3.21M |
2019 Q1
0 quarters
|
|
47
BioMarin Pharmaceuticals
BMRN
$10.8B
| $2.97M | 0.11% |
33,400
+23,000
| +221% | +$2.13M |
2018 Q4
1 quarter
|
|
48
PUT
BioCryst Pharmaceuticals
BCRX
$2.05B
| $2.93M | 0.11% |
+359,600
| New | +$3.08M |
2019 Q1
0 quarters
|
|
|
49
CALL
BioCryst Pharmaceuticals
BCRX
$2.05B
| $2.9M | 0.11% |
+355,800
| New | +$3.05M |
2019 Q1
0 quarters
|
|
50
DELISTED
TIER REIT, Inc.
TIER
| $2.87M | 0.11% |
+100,000
| New | +$2.37M |
2019 Q1
0 quarters
|
|
Similar funds
FFM
AWA
SC
HCM
NB
WFA
RIM
AU
DLD Asset Management's Q1 2019 Portfolio in Review
As of Q1 2019, DLD Asset Management held 138 positions worth $2.72B, up 86% from $1.46B the previous quarter. Its ten largest holdings account for 63% of the portfolio.
DLD Asset Management withdrew a net $390M in Q1 2019, closing 39 positions and reducing 11 holdings. Its most notable exit was Shire pic, an estimated $38M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 79% of assets, up from 67% a quarter earlier, followed by Healthcare and Technology.
Against the trend, DLD Asset Management opened a new position in Biogen worth $82M.
- DLD Asset Management's largest Q1 2019 buy was Biogen: 346,700 shares worth $82M.
- DLD Asset Management added most to L3 Technologies, Inc. in Q1 2019, an estimated $9.9M increase.
- DLD Asset Management's biggest Q1 2019 reduction was Qualcomm, cutting an estimated $62.5M.
- DLD Asset Management fully exited Shire pic in Q1 2019, selling an estimated $38M.
- DLD Asset Management's ten largest holdings make up 63% of its $2.72B portfolio in Q1 2019.
- DLD Asset Management opened 54 new positions and closed 39 in Q1 2019.
- DLD Asset Management's portfolio value rose 86% quarter-over-quarter to $2.72B.
Based on DLD Asset Management's 13F filing for Q1 2019, filed 14 May 2019.